Drug Shortage Report for SEPTA-CITALOPRAM
Report ID | 63580 |
Drug Identification Number | 02355272 |
Brand name | SEPTA-CITALOPRAM |
Common or Proper name | Citalopram Hydrobromide |
Company Name | SEPTA PHARMACEUTICALS INC |
Market Status | DORMANT |
Active Ingredient(s) | CITALOPRAM |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100s |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-10-10 |
Estimated end date | 2019-01-31 |
Actual end date | 2019-01-17 |
Shortage status | Resolved |
Updated date | 2019-01-22 |
Company comments | Supply delay |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7035 MAXWELL ROAD, UNIT # 2 MISSISSAUGA, ONTARIO CANADA L5S 1R5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2019-01-22 | French | Compare |
v7 | 2019-01-22 | English | Compare |
v6 | 2018-12-17 | French | Compare |
v5 | 2018-12-17 | English | Compare |
v4 | 2018-10-11 | English | Compare |
v3 | 2018-10-09 | French | Compare |
v2 | 2018-10-09 | English | Compare |
v1 | 2018-10-09 | English | Compare |
Showing 1 to 8 of 8